Comparison of different estimation procedures for proportional hazards model with random effects

Computational Statistics and Data Analysis

Volumn 51, Issue 8, 2007, Pages 3913-3930

  Abrahantes, José Cortiñas ^a   Legrand, Catherine ^b   Burzykowski, Tomasz ^a   Janssen, Paul ^a   Ducrocq, Vincent ^c   Duchateau, Luc ^d  

^a HASSELT UNIVERSITY   (Belgium)

^b EORTC DATA CENTER   (Belgium)

^c CEMAGREF   (France)

^d GHENT UNIVERSITY   (Belgium)

Author keywords

Frailty model; Laplace approximation; Multivariate failure time data; Penalized partial likelihood; Restricted or residual maximum likelihood

Indexed keywords

COMPUTER SIMULATION; ESTIMATION; HAZARDS; LAPLACE EQUATION; MATHEMATICAL MODELS; PROPORTIONAL CONTROL SYSTEMS;

FRAILTY MODELS; LAPLACE APPROXIMATION; MULTIVARIATE FAILURE-TIME DATA; PENALIZED PARTIAL LIKELIHOOD; RESIDUAL MAXIMUM LIKELIHOOD;

DATA REDUCTION;

EID: 33947667898     PISSN: 01679473     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.csda.2006.03.009     Document Type: Article

References (43)

1. Bouffioux C., Denis L., Oosterlinck W., Viggiano G., Vergison B., Keuppens F., de Pauw M., Sylvester R., and Cheuvart B. Adjuvant chemotherapy of recurrent superficial transitional cell carcinoma: results of a European Organization for Research and Treatment of Cancer randomised trial comparing intravesical instillation of thiotepa, doxorubicin and cisplatin. J. Urology 148 (1992) 297-301
2. Bouffioux C., Kurth K.H., Bono A., Oosterlinck W., Kruger C.B., de Pauw M., and Sylvester R. Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of two European Organization for Research and Treatment of Cancer randomized trials with mitomycin C and doxorubicin comparing early versus delayed instillations and short-term versus long-term treatment European Organization for Research and Treatment of Cancer Genitourinary Group. J. Urology 153 (1995) 934-941
3. Breslow N.E., and Clayton D.G. Approximate inference in generalized linear models. J. Amer. Statist. Assoc. 88 (1993) 9-25
4. Clahsen P.C., van de Velde C.J., Julien J.P., Floiras J.L., Delozier T., Mignolet F.Y., and Sahmoud T.M. Improved local control and disease-free survival after preoperative chemotherapy for early-stage breast cancer. A European Organization for Research and Treatment of Cancer breast cancer cooperative group study. J. Clinical Oncology 14 (1996) 745-753
5. Clayton D.G. A model for association in bivariate life tables and its application in epidemiological studies of familial tendency in chronic disease incidence. Biometrika 65 (1978) 141-151
6. Cortiñas, A.J., Burzykowski, T., 2005. A version of the EM algorithm for proportional hazards model with random effects. Biometrical J. 47, 847-862.
7. Duchateau L., Janssen P., Lindsey P., Legrand C., Nguti R., and Sylvester R. The shared frailty model and the power for heterogeneity tests in multicenter trials. Comput. Statist. Data Anal. 40 (2002) 603-620
8. Ducrocq V., and Casella G. A Bayesian analysis of mixed survival models. Genet. Sel. Evol. 28 (1996) 505-529
9. Ducrocq, V., Sölkner, J., 1994. The Survival Kit, a FORTRAN package for the analysis of survival data. Fifth World Congress on Genetics Applied to Livestock Production, vol. 22, Department of Animal of Poultry Science, University of Guelph, Guelph, Ont., Canada, pp. 51-52.
10. Ducrocq, V., Sölkner, J., 1998. The Survival Kit-V3.0 a package for large analyses of survival data. Sixth World Congress on Genetics Applied to Livestock Production, vol. 27, Animal Genetics and Breeding Unit, University of New England, Armidale, Australia, pp. 447-448.
11. Gustafson P. Large hierarchical Bayesian analysis of multivariate survival data. Biometrics 53 (1997) 230-242
12. Ha I.D., and Lee Y. Estimating frailty models via Poisson hierarchical generalized linear models. J. Comput. Graphical Statist. 12 (2003) 663-681
13. Ha I.D., Lee Y., and Song J. Hierarchical likelihood approach for frailty models. Biometrika 88 (2001) 233-243
14. Hougaard P. Analysis of Multivariate Survival Data (2000), Springer, New York
15. Klein J.P., and Moeschberger M.L. Survival Analysis Techniques for Censored and Truncated Data (1997), Springer, New York
16. Kurth K.H., Schröder F.H., Tunn U., Ay R., Pavone-Macaluso M., Debruyne F., dePauw M., Dalesio O., and tenKate F. Adjuvant treatment of superficial transitional cell bladder carcinoma: preliminary results of an European Organization for Research and Treatment of Cancer randomized trial comparing doxorubicin hydrochloride, ethoglucid and transurethral resection alone. J. Urology 132 (1984) 258-262
17. Legrand, C., Ducrocq, V., Janssen, P., Sylvester, R., Duchateau, L., 2005. A Bayesian approach to jointly estimate center and treatment by center heterogeneity in a proportional hazards model. Statist. Medicine 24, 3789-3804.
18. Liu D.C., and Nocedal J. On the limited memory BFGS method for large scale optimization. Math. Programming 45 (1989) 503-528
19. Louis T.A. Finding the observed information matrix when using the EM algorithm. J. Roy. Statist. Soc. (Ser. B) 44 (1982) 190-200
20. Ma R., Krewski D., and Burnett R.T. Random effects Cox models: a Poisson modelling approach. Biometrika 90 (2003) 157-169
21. Maples J.J., Murphy S.A., and Axinn W.G. Two-level proportional hazards models. Biometrics 58 (2002) 754-763
22. McGilchrist C.A. REML estimation for survival models with frailty. Biometrics 49 (1993) 221-225
23. McGilchrist C.A. Estimation in generalized mixed models. J. Roy. Statist. Soc. (Ser. B) 56 (1994) 61-69
24. McGilchrist C.A., and Aisbett C.W. Regression with frailty in survival analysis. Biometrics 47 (1991) 461-466
25. Nelder J.A., and Mead R. A simplex method for function minimization. Comput. J. 7 (1965) 308-313
26. Newling D.W., Robinson M.R., Smith P.H., Byar D., Lockwood R., Stevens I., De Pauw M., and Sylvester R. Tryptophan metabolites, pyridoxine (vitamin B6) and their influence on the recurrence rate of superficial bladder cancer Results of a prospective randomized phase III study performed by the EORTC GU Group. EORTC Genitourinary Tract CancerCooperative Group. European Urologist 27 (1995) 110-116
27. Oakes D. A model for association in bivariate survival data. J. Roy. Statist. Soc. (Ser. B) 44 (1982) 414-422
28. Oosterlinck W., Kurth K.H., Schröder F.H., Bultinck J., Hammond B., and Sylvester R. A prospective European Organization for Research and Treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage TaT1 papillary carcinoma of the bladder. J. Urology 149 (1993) 749-752
29. Ripatti S., and Palmgren J. Estimation of multivariate frailty models using penalized partial likelihood. Biometrics 56 (2000) 1016-1022
30. Ripatti S., Larsen K., and Palmgren J. Maximum likelihood inference for multivariate frailty models using an automated Monte Carlo EM algorithm. Lifetime Data Anal. 8 (2002) 349-360
31. Royston P., Parmar M.K.B., and Sylvester R. Construction and validation of a prognostic model across several studies, with an application in superficial bladder cancer. Statist. Medicine 23 (2004) 907-926
32. Sargent D. A general framework for random effects survival analysis in the Cox proportional hazard setting. Biometrics 54 (1998) 1486-1497
33. Sastry N. A nested frailty model for survival data, with an application to the study of child survival in northeast Brazil. J. Amer. Statist. Assoc. 92 (1997) 426-435
34. Schall R. Estimation in generalised linear models with random effects. Biometrika 78 (1991) 719-727
35. Sinha D., and Dey D. Semiparametric Bayesian analysis of survival data. J. Amer. Statist. Assoc. 92 (1997) 1195-1212
36. Therneau, T., 2003. On mixed effect Cox models, sparse matrices, and modelling data from large pedigree. Technical Report, July 2003.
37. Vaida F., and Xu R. Proportional hazards model with random effects. Statist. Medicine 19 (2000) 3309-3324
38. Vaupel J.W., Manton K.G., and Stallard E. The impact of heterogeneity in individual frailty on the dynamics of mortality. Demography 16 (1979) 439-454
39. Witjes J.A., van der Meijden A.P., Sylvester R.C., Debruyne F.M., van Aubel A., and Witjes W.P. Long term follow up of an EORTC randomized prospective trial comparing intravesical bacille Calmette-Guérin-RIVM and Mitomycin C in superficial bladder cancer. Urology 52 (1998) 403-410
40. Xue X. Multivariate survival data under bivariate frailty: an estimating equation approach. Biometrics 54 (1998) 1631-1637
41. Xue X. Analysis of childhood brain tumor data in New York City using frailty models. Statist. Medicine 20 (2001) 3459-3473
42. Xue X., and Brookmeyer R. Bivariate frailty model for the analysis of multivariate survival time. Lifetime Data Anal. 2 (1996) 277-289
43. Xue X., and Ding Y. Assessing heterogeneity and correlation of paired failure times with the bivariate frailty model. Statist. Medicine 18 (1999) 907-918